PDF herunterladen
pferde spiegel 2020; 23(01): 27-37
DOI: 10.1055/a-0976-5362
CVE-Fortbildung
Georg Thieme Verlag KG Stuttgart · New York

Diagnostik und Management der equinen Keratomykose

Sonja Weiß
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
19. März 2020 (online)

Auch verfügbar auf
    Lizenzen und Reprints Alle Artikel dieser Rubrik

Die equine Keratomykose ist eine schwerwiegende Hornhauterkrankung, die in verschiedenen Formen auftritt. Eine sichere Diagnose mit anschließender frühzeitiger und intensiver Therapie ist wichtig, um bestmögliche Voraussetzungen für Visus- und Bulbuserhalt zu schaffen.

Supporting Information

 

  • Literatur

  • 1 Clode AB. Therapy of equine infectious keratitis: a review. Equine Vet J 2010; 42: 19-23
    CrossrefPubMedGoogle Scholar
  • 2 Voelter-Ratson K, Monod M, Unger L. et al. Evaluation of the conjunctival fungal flora and its susceptibility to antifungal agents in healthy horses in Switzerland. Vet Ophthalmol 2014; 17: 31-36
    CrossrefPubMedGoogle Scholar
  • 3 Brooks DE. Equine keratomycosis: an international problem. Equine Vet Educ 2009; 21: 243-246
    CrossrefGoogle Scholar
  • 4 Sherman AB, Clode AB, Gilger BC. Impact of fungal species cultured on outcome in horses with fungal keratitis. Vet Ophthalmol 2017; 20: 140-146
    CrossrefPubMedGoogle Scholar
  • 5 Reed Z, Thomasy SM, Good KL. et al. Equine keratomycoses in California from 1987 to 2010 (47 cases). Equine Vet J 2013; 45: 361-366
    CrossrefPubMedGoogle Scholar
  • 6 Brooks DE, Andrew SE, Denis HM. et al. Rose bengal positive epithelial microerosions as a manifestation of equine keratomycosis. Vet Ophthalmol 2000; 3: 83-86
    CrossrefPubMedGoogle Scholar
  • 7 Brooks DE, Plummer CE, Mangan BG. et al. Equine subepithelial keratomycosis. Vet Ophthalmol 2013; 16: 93-96
    CrossrefPubMedGoogle Scholar
  • 8 Maxwell KM, Plummer CE, Brooks DE. The fungal plaque form of equine keratomycosis. Vet Med Anim Sci 2015; 3: 2
    CrossrefGoogle Scholar
  • 9 Galán A, Martín-Suárez EM, Gallardo JM. et al. Clinical findings and progression of 10 cases of equine ulcerative keratomycosis (2004–2007). Equine Vet Educ 2009; 21: 236-242
    CrossrefGoogle Scholar
  • 10 Brooks DE, Taylor DP, Plummer CE. et al. Iris abscesses with and without intralenticular fungal invasion in the horse. Vet Ophthalmol 2009; 12: 306-312
    CrossrefPubMedGoogle Scholar
  • 11 de Linde Henriksen M, Andersen PH, Thomsen PD. et al. Equine deep stromal abscesses (51 cases–2004–2009)–Part 1: the clinical aspects with attention to the duration of the corneal disease, treatment history, clinical appearance, and microbiology results. Vet Ophthalmol 2014; 17: 6-13
    CrossrefPubMedGoogle Scholar
  • 12 Ollivier FJ. Medical and surgical management of melting corneal ulcers exhibiting hyperproteinase activity in the horse. Clin Tech Equine Prac 2005; 4: 50-71
    Google Scholar
  • 13 Galera PD, Brooks DE. Optimal management of equine keratomycosis. Veterinary Medicine: Research and Reports 2012; 3: 7
    Google Scholar
  • 14 Brilhante RSN, Bittencourt PV, de Souza Collares Castelo-Branco D. et al. Biofilms of Candida spp. from the ocular conjunctiva of horses with reduced azole susceptibility: a complicating factor for the treatment of keratomycosis?. Vet Ophthalmol 2017; 20: 539-546
    CrossrefPubMedGoogle Scholar
  • 15 Ledbetter EC, Scarlett JM. In vivo confocal microscopy of the normal equine cornea and limbus. Vet Ophthalmol 2009; 12: 57-64
    CrossrefPubMedGoogle Scholar
  • 16 Matthews AG. Ophthalmic antimicrobial therapy in the horse. Equine Vet Educ 2009; 21: 271-280
    CrossrefGoogle Scholar
  • 17 Pearce JW, Giuliano EA, Moore CP. In vitro susceptibility patterns of Aspergillus and Fusarium species isolated from equine ulcerative keratomycosis cases in the midwestern and southern United States with inclusion of the new antifungal agent voriconazole. Vet Ophthalmol 2009; 12: 318-324
    CrossrefPubMedGoogle Scholar
  • 18 Gilmour MA. Subconjunctival voriconazole for the treatment of mycotic keratitis in a horse. Equine Vet Educ 2012; 24: 489-492
    CrossrefGoogle Scholar
  • 19 Tsujita H, Plummer CE. Corneal stromal abscessation in two horses treated with intracorneal and subconjunctival injection of 1 % voriconazole solution. Vet Ophthalmol 2013; 16: 451-458
    CrossrefPubMedGoogle Scholar
  • 20 Ford MM. Antifungals and their use in veterinary ophthalmology. Vet Clin Small Anim 2004; 34: 669-691
    CrossrefPubMedGoogle Scholar
  • 21 Brooks DE, Matthews A, Clode AB. Diseases of the cornea. In: Equine ophthalmology. 3rd edition. Ames, IA: Blackwell Publishing; 2017: 305-322
    Google Scholar
  • 22 Ollivier FJ, Gilger BC, Barrie KP. et al. Proteinases of the cornea and preocular tear film. Vet Ophthalmol 2007; 10: 199-206
    CrossrefPubMedGoogle Scholar
  • 23 Plummer CE. The use of amniotic membrane transplantation for ocular surface reconstruction: a review and series of 58 equine clinical cases (2002–2008). Vet Ophthalmol 2009; 12: 17-24
    CrossrefPubMedGoogle Scholar
  • 24 Brooks DE. Penetrating keratoplasty, deep lamellar endothelial keratoplasty, and posterior lamellar keratoplasty in the horse. Clin Tech Equine Prac 2005; 4: 37-49
    Google Scholar
  • 25 Andrew SE, Brooks DE, Smith PJ, Gelatt KN. et al. Equine ulcerative keratomycosis: visual outcome and ocular survival in 39 cases (1987–1996). Equine Vet J 1998; 30: 109-116
    CrossrefPubMedGoogle Scholar
  • 26 Mustikka MP, Grönthal TS, Pietilä EM. Equine infectious keratitis in Finland: Associated microbial isolates and susceptibility profiles. Vet Ophthalmol 2019; 00: 1-12
    Google Scholar